AXA INVESTMENT MANAGERS: DRIVING ESG LEADERSHIP
CHALLENGE
As a global investment management firm with $1 trillion in assets under management, France-based AXA IM was anxious to get their point of view across more strongly in the Americas, particularly in the areas of specialty thematic investing. This encompassed its “clean economy” practice, where it launched a strategy to provide access to clean tech, as well as their biotech strategy, which became increasingly relevant with the mass production of vaccines to combat the COVID-19 virus
SOLUTION
Taking a multi-pronged approach, the team incorporated AXA IM’s ESG and biotech expertise in its external communications with media, and conducted in-depth discovery meetings with each of the spokespeople to extract key message points for outreach
RESULTS
As a result, we secured media opportunities with top tier and ESG outlets, and also arranged an editorial board meeting with the Wall Street Journal, where ESG was a major topic. Additional coverage was secured on vaccine thought leadership at the height of the conversation on this theme in Q4 2020, resulting in interviews/coverage with Business Insider, Quartz and Bloomberg.
